Methylene Blue is a medicine that has been in use since the late 1800s, having a wide range of clinical applications. It is the oldest synthetic antimalarial drug, and is used in surgical staining and for treating methemoglobinemia. Positive mitochondrial effects have resulted in a resurgence in popularity of this medicine.
Methylene Blue is a catalytic redox cycler in the mitochondria. This directly supports energy production via the synthesis of ATP and the reduction of oxidative stress.
There is a growing sentiment in the medical community that the loss of mitochondrial function results in the aging of tissues. Therefore, methylene blue is at the forefront of anti-aging movements. By improving ATP production and oxygen utilization, the energy inducing benefits of methylene blue can be a game changer!